Blue Owl Capital Holdings »

Pliant Therapeutics shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $54M 3.0M 18.11

More positions owned by Blue Owl Capital Holdings

Pliant Therapeutics (PLRX)
Robinhood Mkts Com Cl A (HOOD)
Cullinan Oncology (CGEM)
Tourmaline Bio (TRML)
Klaviyo Com Ser A (KVYO)
Owl Rock Capital Corporation (OBDC)
Repare Therapeutics Ord (RPTX)
Acelyrin (SLRN)
Larimar Therapeutics (LRMR)
Keros Therapeutics (KROS)
Ultragenyx Pharmaceutical (RARE)
Engene Holdings (ENGN)
Syros Pharmaceuticals Com New (SYRS)
Disc Medicine (IRON)
E2open Parent Holdings Com Cl A (ETWO)

View all positions for Blue Owl Capital Holdings

Top funds holding Pliant Therapeutics

T. Rowe Price Associates
First Light Asset Management
Laurion Capital Management
Vanguard Group
Blue Owl Capital Holdings
Redmile Group
Trv Gp Iv
Dr. Jeffrey R. Jay, M.D.
Citadel Advisors
Franklin Resources
Casdin Capital
RA Capital Management
Deutsche Bank Aktiengesellschaft
Bessemer
Candriam Luxembourg S.C.A.

View all funds holding Pliant Therapeutics